ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1174

Prevalence of Subclinical Sacroiliitis in Young Patients with Inflammatory Bowel Disease Revealed by Entero-MRI

Teresa Giani1, Marco Di Maurizio 2, Paolo Lionetti 2, Azzurra Bernardini 2, Giovanna Ferrara 1, Viola Filistrucchi 2 and Rolando Cimaz 3, 1Anna Meyer Children University Hospital, Florence, Italy, 2A. Meyer Children University Hospital, Florence, Italy, 3Meyer Children's Hospital in Florence, Florence, Italy

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: inflammatory bowel disease (IBD) and magnetic resonance imaging (MRI), juvenile idiopathic arthritis (JIA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Imaging Of Rheumatic Diseases Poster II

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Sacroiliitis is one of the extraintestinal manifestations associated with inflammatory bowel disease (IBD), and may be underdiagnosed especially in the pediatric age. MR-enterography (Entero-MRI)  is currently the imaging gold standard to assess intestinal disease activity  and to detect complications in patients with IBD. Only few studies have been conducted on adult patients with IBD in order to define the role of this technique in assessing sacroiliitis, while no data are available on pediatric patients.
To study the prevalence of inflammatory sacroiliitis on MRI performed for intestinal investigation in an IBD pediatric population. 

Methods: This is a retrospective study conducted on patients suffering from IBD followed in our gastroenterology department  between 2010 and 2018 whose entero-RM (1.5 or 3 Tesla, Philips depending from year of scanning) were blindly and independently scored by two readers experienced in pediatric musculoskeletal imaging. Each sacroiliac joint was divided into 4 quadrants. Signs of sacroiliitis were identified according to the ASAS criteria, with a particular attention to the presence of bone marrow edema (using T2 weighted sequences with fat suppression), diffusion restriction in DWI sequences (Diffusion Weighted Imaging) or DWIBS (Diffusion Weighted Imaging with Background Suppression) and post-contrastographic uptake in dynamic acquisitions. Demographics, IBD characteristics, clinical, radiological, and laboratory data were recorded and a dedicated Excel database was constructed. Results were elaborated using descriptive statistics.

Results: 34 patients (10 F, 24 M, age at scanning range 5-20 yrs, median 15) were included in the study, for a total of 59 entero-MRI evaluated (some patients were subjected to more than one scan). Two out of 34 patients were affected by Ulcerative Colitis, 32 by Crohn disease. Joint examination resulted negative in all patients, and none complained of articular symptoms including back pain.

In 5 IBD patients (4 CD, 1 UC) a monolateral slight degree of sacroiliitis (grade 1) was radiologically identified. They were all males, without clinical-laboratory-radiologic inflammatory signs of intestinal activity, with the exception of a patient who presented signs of intestinal and sacroiliac inflammation at his first entero-MRI, while 18 months later, at his MRI control under pharmacological treatment, signs of sacroiliitis were still present in the absence of intestinal signs of inflammation.

Conclusion: Asymptomatic sacroiliitis was observed in  about 15% of our IBD patients. Sacroiliac involvement therefore can be underdiagnosed in these patients. Entero-MRI with specific sequences could be a good tool to detect  early signs of sacroiliac inflammation.
References

  1. Leclerc-Jacob S, Lux G, Rat AC. et al. The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients. Aliment Pharmacol Ther 2014; 39: 957-962.
  2. J P Bray T, Vendhan K, Ambrose N. et al. Diffusion-weighted imaging is a sensitive biomarker of response to biologic therapy in enthesitis-related arthritis. Rheumatology 2017; 56: 399-407.

Disclosure: T. Giani, None; M. Di Maurizio, None; P. Lionetti, None; A. Bernardini, None; G. Ferrara, None; V. Filistrucchi, None; R. Cimaz, None.

To cite this abstract in AMA style:

Giani T, Di Maurizio M, Lionetti P, Bernardini A, Ferrara G, Filistrucchi V, Cimaz R. Prevalence of Subclinical Sacroiliitis in Young Patients with Inflammatory Bowel Disease Revealed by Entero-MRI [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/prevalence-of-subclinical-sacroiliitis-in-young-patients-with-inflammatory-bowel-disease-revealed-by-entero-mri/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-subclinical-sacroiliitis-in-young-patients-with-inflammatory-bowel-disease-revealed-by-entero-mri/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology